←
Stuart Smith247 posts
Stuart Smith avatar

Stuart Smith

@SjsmithStuart
◷ Joined March 2015▧ 8 Photos and videos
Stuart Smith avatar
Stuart Smith@SjsmithStuart·Nov 15

Great talk by Dr Simon Deacon @NeuroOnc SNO meeting updating the Nottingham ROBIN cohort results. Long read sequencing with @nanopore gives rapid accurate detailed molecular diagnoses for brain tumours!

Post attachmentPost attachment
Stuart Smith avatar
Stuart Smith@SjsmithStuart·Oct 12

Prof Ruman Rahman making the case really strongly for more discovery and translational science investment for brain tumours in the UK on BBC Breakfast

Post attachment
King's Neurosurgery avatar
⟳ Stuart Smith retweeted
King's Neurosurgery@KingsNeuro·Oct 5

🧠 Can non-invasive brain stimulation predict glioblastoma survival before surgery? 1/5 Our study @KingsCollegeNHS evaluated 77 patients with motor-eloquent grade 4 IDH-wildtype glioblastoma undergoing surgical resection followed by Stupp protocol. 👇 @lavrador_jose @Sabzp87

Post attachment
The Lancet avatar
⟳ Stuart Smith retweeted
The Lancet@TheLancet·Sep 25

Radiotherapy after surgery halves risk of recurrence in a type of brain tumour that can often grow back, trial shows. Find out more in The Lancet: spkl.io/60137TUFS #EANO2026

Post attachment
Mario Nawfal avatar
⟳ Stuart Smith retweeted
Mario Nawfal@MarioNawfal·Sep 2

🇬🇧 A “revolutionary” new procedure at London’s St Thomas’ Hospital can identify the cause of an infection with a single test, potentially within hours instead of days. Using an Oxford Nanopore GridION, it sequences genetic material in a patient sample and searches simultaneously for bacteria, viruses and fungi. For critically ill patients, that could mean finding the infection and choosing the right treatment far faster, while reducing unnecessary use of broad-spectrum antibiotics. It's not yet clear when the test could be made widely available, but it's the first step of a massive shift in the efficiency of diagnosing health issues everywhere. Writer: Mhedi

1:55
NEJM avatar
⟳ Stuart Smith retweeted
NEJM@NEJM·Jun 3

In a trial involving children with Chiari type I malformation and syringomyelia, the percentage with surgical complications did not differ significantly between posterior fossa decompression with duraplasty and decompression alone. Full trial results and Research Summary: nej.md/3RtZTQR

Post attachment
Oxford Nanopore avatar
⟳ Stuart Smith retweeted
Oxford Nanopore@nanopore·6 Aug 2025

Traditional brain tumour characterisation requires a battery of tests, delaying critical treatment decisions. Discover how Oxford Nanopore sequencing streamlines this with a single, rapid assay to provide high-confidence tumour methylation profiling. nanoporetech.com/application…

1:27
BNOS avatar
⟳ Stuart Smith retweeted
BNOS@BNOSofficial·20 Jun 2025

Our winner of the Young Investigator Award 2025 is Phoebe McCrorie. Congratulations! Thank you to Karen Noble at Brain Tumour Research for supporting this alongside BNOS. Photo - Karen Noble, Phoebe McCrorie, Susan Short. #BNOS2025

Post attachment
Oxford Nanopore avatar
⟳ Stuart Smith retweeted
Oxford Nanopore@nanopore·22 May 2025

A breakthrough moment in brain infections. Faced with a mystery infection, Judith Breuer sequenced a biopsy sample—and identified a pathogen never before linked to brain infections. Find out more. #NanoporeConf

0:39
Oxford Nanopore avatar
⟳ Stuart Smith retweeted
Oxford Nanopore@nanopore·22 May 2025

Why wait weeks for a diagnosis? Danny Miller discusses the future potential of Oxford Nanopore sequencing, and how clinicians could get actionable results within hours—not days or weeks. No need to batch samples. Same-day sequencing, same-day answers. #NanoporeConf

0:27
Oxford Nanopore avatar
⟳ Stuart Smith retweeted
Oxford Nanopore@nanopore·22 May 2025

In the studio, Matt Loose shares how: “Surgeons were literally knocking, saying I’ve got a patient today. Once people see what’s possible, they start to believe it — and get excited.” when talking about his new CNS tumour profiling method.

0:33
Oxford Nanopore avatar
⟳ Stuart Smith retweeted
Oxford Nanopore@nanopore·22 May 2025

Knowledge is power. In the studio, Matt Loose shared insights on rapid CNS profiling — and how one participant told him: “Even if the answer isn’t what you want, it’s better than not knowing at all.”

0:33
Less Survivable Cancers Taskforce avatar
⟳ Stuart Smith retweeted
Less Survivable Cancers Taskforce@LessSurvivable·21 May 2025

Great news about a new test that reduces diagnosis time for certain types of brain tumour. This highlights the importance of continued research to improve earlier diagnosis and faster detection for the less survivable cancers. bbc.co.uk/news/articles/cpvk…